CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Ordinary Shares/ Common Stock	Treasury Shares	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2021			157,237,435
Beginning balance at Dec. 31, 2021	$ 1,081,618	$ (1,545)	$ 157,237	$ 0	$ 1,670,033	$ (7,135)	$ (738,517)	$ (1,545)
Beginning balance (in shares) at Dec. 31, 2021				0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	14,649				14,649
Ordinary shares issued related to share-based compensation (in shares)			5,952,992
Ordinary shares issued related to founders advisory fees - related party	0		$ 5,954		(5,954)
Liability portion of founders advisory fees - related party reclassified to additional paid in capital	19,568				19,568
Warrants exercised (in shares)			44,115
Warrants exercised	529		$ 44		485
Ordinary shares repurchased (in shares)				6,436,736
Ordinary shares repurchased	(49,341)			$ (49,341)
Net (loss) income	91,758						91,758
Other comprehensive income (loss)	(18,336)					(18,336)
Ending balance (in shares) at Dec. 31, 2022			163,234,542
Ending balance at Dec. 31, 2022	1,138,900		$ 163,235	$ (49,341)	1,698,781	(25,471)	(648,304)
Ending balance (in shares) at Dec. 31, 2022				6,436,736
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	1,596				1,596
Ordinary shares issued related to share-based compensation (in shares)			1,831,653
Ordinary shares issued related to founders advisory fees - related party	0		$ 1,832		(1,832)
Liability portion of founders advisory fees - related party reclassified to additional paid in capital	2,618				2,618
Ordinary shares repurchased (in shares)				12,178,454
Ordinary shares repurchased	(64,066)			$ (64,066)
Net (loss) income	67,486						67,486
Other comprehensive income (loss)	$ 5,761					5,761
Ending balance (in shares) at Dec. 31, 2023	165,066,195		165,066,195
Ending balance at Dec. 31, 2023	$ 1,152,295		$ 165,067	$ (113,407)	1,701,163	(19,710)	(580,818)
Ending balance (in shares) at Dec. 31, 2023	18,615,190			18,615,190
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	$ 12,849				12,849
Ordinary shares issued related to share-based compensation (in shares)			1,758,464
Ordinary shares issued related to founders advisory fees - related party	0		$ 1,758		(1,758)
Liability portion of founders advisory fees - related party reclassified to additional paid in capital	8,464				8,464
Warrants exercised (in shares)			2,601,455
Warrants exercised	23,509		$ 2,601		20,908
Ordinary shares repurchased (in shares)				2,988,291
Ordinary shares repurchased	(14,420)			$ (14,420)
Change to par value common stock	0		$ (169,409)		169,409
Net (loss) income	(5,905)						(5,905)
Other comprehensive income (loss)	$ (19,522)					(19,522)
Ending balance (in shares) at Dec. 31, 2024	169,426,114		169,426,114
Ending balance at Dec. 31, 2024	$ 1,157,270		$ 17	$ (127,827)	$ 1,911,035	$ (39,232)	$ (586,723)
Ending balance (in shares) at Dec. 31, 2024	21,603,481			21,603,481